CVS Health is expanding support for GLP-1 medications with a new $50 monthly copay for eligible Medicare patients through the CMS Medicare GLP-1 Bridge program starting July 1, 2026. They also introduced a $49 virtual MinuteClinic visit for weight management, allowing licensed clinicians to evaluate and prescribe GLP-1 therapy where appropriate. CVS pharmacists will provide personalized guidance and over-the-counter products to help manage common side effects, addressing key barriers to treatment adherence. This comprehensive approach aims to improve access, affordability, and ongoing patient support across CVS's 9,000 pharmacies and MinuteClinic locations.
CVS Health has made updated COVID-19 vaccines for 2026-2027 available at CVS Pharmacy and MinuteClinic locations across the U.S. These vaccines are offered at no cost for most insurance plans, with flexible scheduling including walk-ins and appointme...
CVS Health reported a 7.3% revenue increase in Q2 to $106.1 billion and raised its full-year revenue forecast to at least $414 billion, alongside improved earnings per share guidance. Despite UBS lowering its price target to $118, analysts like Jeffe...
Halper Sadeh LLC is investigating whether CVS Health Corporation's officers and directors breached their fiduciary duties to shareholders. Long-term CVS stockholders may be eligible to seek reforms, financial awards, or other relief. The firm encoura...
